Evidence map›Paper›PMID 36768881›Full record

ArticleInternational journal of molecular sciences2023

Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

María L Espejo-Cruz, Sandra González-Rubio, Juan J Espejo, Javier M Zamora-Olaya, Rafael M Alejandre-Altamirano, María Prieto-Torre, Clara I Linares, Marta Guerrero-Misas, Pilar Barrera-Baena, Antonio Poyato-González and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

María L Espejo-CruzMaimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.
Sandra González-RubioMaimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.
Juan J EspejoMaimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.ORCID 0000-0003-3096-8728
Javier M Zamora-OlayaMaimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.ORCID 0000-0003-2182-4714
Rafael M Alejandre-AltamiranoMaimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.ORCID 0000-0001-6582-982X
María Prieto-TorreMaimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.
Clara I LinaresMaimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.
Marta Guerrero-MisasMaimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.
Pilar Barrera-BaenaMaimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.
Antonio Poyato-GonzálezMaimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.
Marina Sánchez-FríasMaimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.
María D AyllónMaimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.
Manuel L Rodríguez-PerálvarezMaimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.ORCID 0000-0002-1795-2919
Manuel de la MataMaimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.
Gustavo FerrínMaimonides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, 14004 Cordoba, Spain.

Funding

Instituto de Salud Carlos III FI19/00357Instituto de Salud Carlos III PI18/01736Regional Government of Andalusia RH-0010-2021Regional Government of Andalusia RH-0075-2020
6 · The paper itself

Abstract

Circulating tumor cells (CTCs), and particularly circulating cancer stem cells (cCSC), are prognostic biomarkers for different malignancies and may be detected using liquid biopsies. The ex vivo culture of cCSCs would provide valuable information regarding biological aggressiveness and would allow monitoring the adaptive changes acquired by the tumor in real time. In this prospective pilot study, we analyzed the presence of EpCAM

Indexed as

Carcinoma, HepatocellularChemoembolization, TherapeuticLiver NeoplasmsNeoplastic Cells, CirculatingAgedBiomarkers, TumorFemaleHumansMaleMiddle AgedPilot ProjectsProspective StudiesBiomarkers, Tumorcirculating cancer stem cellscirculating tumor cellshepatocellular carcinomaliquid biopsyspheroidstransarterial chemoembolization

Identifiers

PMID36768881
PMCPMC9916725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.